Is thymosin action mediated by prostaglandin release? 1983

C Rinaldi Garaci, and C Favalli, and V Del Gobbo, and E Garaci, and B M Jaffe

Treatment of spleen cells derived from adult thymectomized mice with thymosin fraction 5 resulted in a rapid and dose-dependent stimulation of the release of immunoreactive prostaglandin E2. The release of prostaglandin E2 was associated with induction of theta antigen and was totally inhibited by indomethacin. In contrast, prostaglandin E2 release from spleen cells from intact donors was inhibited by treatment with fraction 5. The data support the concept that prostaglandin E2 mediates the effects of thymosin fraction 5 on lymphocytes.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D013934 Thymectomy Surgical removal of the thymus gland. (Dorland, 28th ed) Thymectomies
D013947 Thymosin Thymosin. A family of heat-stable, polypeptide hormones secreted by the thymus gland. Their biological activities include lymphocytopoiesis, restoration of immunological competence and enhancement of expression of T-cell characteristics and function. They have therapeutic potential in patients having primary or secondary immunodeficiency diseases, cancer or diseases related to aging. Thymosin Fs,Thymosins

Related Publications

C Rinaldi Garaci, and C Favalli, and V Del Gobbo, and E Garaci, and B M Jaffe
June 1990, Thymus,
C Rinaldi Garaci, and C Favalli, and V Del Gobbo, and E Garaci, and B M Jaffe
January 1985, Bollettino della Societa italiana di biologia sperimentale,
C Rinaldi Garaci, and C Favalli, and V Del Gobbo, and E Garaci, and B M Jaffe
November 1991, The Journal of physiology,
C Rinaldi Garaci, and C Favalli, and V Del Gobbo, and E Garaci, and B M Jaffe
February 1998, Hypertension (Dallas, Tex. : 1979),
C Rinaldi Garaci, and C Favalli, and V Del Gobbo, and E Garaci, and B M Jaffe
November 1981, The Journal of pharmacology and experimental therapeutics,
C Rinaldi Garaci, and C Favalli, and V Del Gobbo, and E Garaci, and B M Jaffe
January 1988, Pharmacology,
C Rinaldi Garaci, and C Favalli, and V Del Gobbo, and E Garaci, and B M Jaffe
January 1976, Brain research bulletin,
C Rinaldi Garaci, and C Favalli, and V Del Gobbo, and E Garaci, and B M Jaffe
May 2006, European journal of pharmacology,
C Rinaldi Garaci, and C Favalli, and V Del Gobbo, and E Garaci, and B M Jaffe
September 2004, American journal of physiology. Renal physiology,
C Rinaldi Garaci, and C Favalli, and V Del Gobbo, and E Garaci, and B M Jaffe
March 1978, Experientia,
Copied contents to your clipboard!